StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
18228
This month
281
This week
53
This year
1697
Today
1
Yesterday
16
Publishing Date
2024 - 04 - 18
1
2024 - 04 - 17
15
2024 - 04 - 16
19
2024 - 04 - 15
18
2024 - 04 - 12
7
2024 - 04 - 11
21
2024 - 04 - 10
28
2024 - 04 - 09
41
2024 - 04 - 08
26
2024 - 04 - 07
3
2024 - 04 - 06
1
2024 - 04 - 05
14
2024 - 04 - 04
22
2024 - 04 - 03
18
2024 - 04 - 02
24
2024 - 04 - 01
23
Sector
Administrative and support and waste management and remediation services
1
Commercial services
1
Communications
1
Consumer non-durables
1
Consumer services
1
Distribution services
3
Electronic technology
2
Finance
7
Finance and insurance
1
Health care and social assistance
4
Health technology
201
Information
1
Manufacturing
17
Mining, quarrying, and oil and gas extraction
2
N/a
15
Process industries
2
Professional, scientific, and technical services
23
Technology services
8
Tags
Acquisition
3
Advanced
5
Agreement
5
Als
3
Alzheimer’s
3
Application
3
Association
15
Biopharma
10
Biotech-beach
7
Business
10
Cancer
24
Candidate
4
Cell
13
Clinical-trials-phase-ii
4
Collaboration
8
Conference
27
Congress
6
Direct
4
Disease
9
Drug
6
Employee
5
Events
5
Expansion
5
Fda
7
Financial
22
First
16
For
42
Genetown
7
Grants
9
Layoffs
7
Management
5
Market
7
Medical
7
Meeting
31
Million
18
N/a
208
Nasdaq
15
Neurology
6
Offering
12
Ongoing
7
People
6
Pharm-country
6
Pipeline
6
Platform
4
Positive
8
Potential
7
Preclinical
15
Presentation
4
Research
23
Results
34
Study
15
Therapeutics
205
Therapy
7
Topline
6
Treatment
12
Trial
26
Tumors
7
Update
12
World
4
Year
7
Entities
Abbvie inc.
4
Abeona therapeutics inc.
2
Achilles therapeutics plc - adr
2
Acrivon therapeutics, inc.
3
Adc therapeutics sa
4
Addex therapeutics ltd
3
Akari therapeutics plc
2
Aligos therapeutics, inc.
2
Allarity therapeutics, inc.
2
Alphabet inc.
8
Altamira therapeutics ltd
2
Alterity therapeutics limited
3
Amarin corporation plc
8
Amgen inc.
2
Applied therapeutics, inc.
2
Aptevo therapeutics inc.
3
Aquestive therapeutics, inc.
2
Arca biopharma, inc.
2
Astrazeneca plc
2
Autolus therapeutics plc
3
Avita medical, inc.
2
Avita therapeutics, inc.
2
Axsome therapeutics, inc.
3
Biora therapeutics inc
4
Black diamond therapeutics, inc.
4
Black spade acquisition co
2
Brainstorm cell therapeutics inc.
7
Briacell therapeutics corp.
2
C4 therapeutics, inc.
3
Cadrenal therapeutics, inc.
2
Calliditas therapeutics ab
3
Candel therapeutics inc
3
Checkpoint therapeutics, inc.
10
Compass therapeutics inc
4
Corcept therapeutics incorporated
3
Eli lilly and company
4
Enlivex therapeutics ltd.
3
Foghorn therapeutics inc.
3
G1 therapeutics, inc.
3
Galapagos nv
8
Johnson & johnson
16
Kintara therapeutics, inc.
3
Medicenna therapeutics corp.
5
Morgan stanley
5
Morphosys ag
8
Nektar therapeutics
8
Neurosense therapeutics ltd.
4
Novartis ag
3
Nurix therapeutics, inc.
10
Oncocyte corporation
8
Onconova therapeutics, inc.
3
Poseida therapeutics, inc.
3
Protara therapeutics, inc.
3
Ptc therapeutics, inc.
9
Qualigen therapeutics, inc.
3
Rallybio corp
9
Sanofi
17
Therapeuticsmd, inc.
8
Tscan therapeutics inc
5
Vaxart, inc.
8
Symbols
ABBV
4
ABEO
2
ABIO
2
ACHL
2
ACRV
3
ADCT
4
ADXN
3
AKTX
2
ALGS
2
ALLR
2
AMGN
2
AMRN
8
APLT
2
APVO
3
AQST
2
ATHE
3
AUTL
3
AVHHL
2
AXSM
3
BCLI
7
BDTX
4
BIOR
4
CADL
3
CALT
3
CCCC
3
CKPT
10
CMPX
4
CORT
3
ENLV
3
FHTX
3
GLPG
8
GLPGF
8
GOOG
8
GOOGL
8
GTHX
3
JNJ
16
KTRA
3
LLY
4
MDNA
5
MDNAF
5
MOR
8
MPSYF
8
MS
5
NKTR
8
NRIX
10
NRSN
4
NVS
3
NVSEF
3
OCX
8
ONTX
3
PSTX
3
PTCT
9
QLGN
3
RLYB
9
SNY
17
SNYNF
17
TARA
3
TCRX
5
TXMD
8
VXRT
8
Exchanges
Amex
8
Nasdaq
268
Nyse
40
Crawled Date
2024 - 04 - 18
2
2024 - 04 - 17
14
2024 - 04 - 16
19
2024 - 04 - 15
18
2024 - 04 - 13
1
2024 - 04 - 12
6
2024 - 04 - 11
21
2024 - 04 - 10
30
2024 - 04 - 09
40
2024 - 04 - 08
27
2024 - 04 - 07
1
2024 - 04 - 06
1
2024 - 04 - 05
14
2024 - 04 - 04
22
2024 - 04 - 03
18
2024 - 04 - 02
24
2024 - 04 - 01
23
Crawled Time
00:00
7
00:20
1
01:00
3
02:00
1
04:00
3
04:20
1
05:00
4
06:00
1
07:00
1
08:00
1
09:00
3
10:00
3
11:00
42
12:00
74
12:30
11
13:00
19
13:30
3
14:00
7
14:30
6
15:00
6
15:30
2
16:00
6
17:00
7
18:00
3
19:00
6
20:00
28
20:20
1
21:00
17
22:00
9
23:00
5
Source
alteritytherapeutics.com
2
neurosense.investorroom.com
2
www.biospace.com
73
www.globenewswire.com
162
www.prnewswire.com
41
www.xortx.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
published :
This month
save search
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-04-18
(Crawled : 05:00)
- globenewswire.com
ADXN
|
$22.8
0.89%
0.88%
16K
|
Health Technology
|
Email alert
Add to watchlist
year
update
therapeutics
financial
results
Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027, Technavio
Published:
2024-04-17
(Crawled : 00:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
market
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
Published:
2024-04-17
(Crawled : 22:00)
- biospace.com/
DMAC
|
News
|
$2.58
8.86%
8.14%
41K
|
Health Technology
|
4.43%
|
O:
4.43%
H:
0.0%
C:
0.0%
dm199
first
stroke
treatment
for
trial
therapeutics
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
Published:
2024-04-17
(Crawled : 20:00)
- prnewswire.com
LGND
|
News
|
$78.93
-1.24%
-1.25%
180K
|
Health Technology
|
Email alert
Add to watchlist
VKTX
|
News
|
$66.53
-2.09%
-2.13%
2M
|
Health Technology
|
Email alert
Add to watchlist
first
report
for
therapeutics
financial
results
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Published:
2024-04-17
(Crawled : 15:00)
- biospace.com/
PSTX
|
News
|
$2.03
0.0%
980K
|
Health Technology
|
0.49%
|
O:
0.0%
H:
2.46%
C:
0.49%
day
pipeline
therapeutics
therapy
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published:
2024-04-17
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$124.53
0.88%
0.0%
2.6M
|
Health Technology
|
0.87%
|
O:
1.22%
H:
0.21%
C:
-0.34%
vent-02
trial
therapeutics
results
Biopharma Layoff Tracker 2024: Fujifilm, Genentech, Sanofi and More Cut Staff
Published:
2024-04-17
(Crawled : 14:00)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
0.63%
|
O:
0.12%
H:
0.51%
C:
0.51%
RLYB
|
News
|
$1.74
-3.33%
-3.45%
520K
|
|
-4.44%
|
O:
-4.44%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-0.2%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
VXRT
|
News
|
$0.8675
-3.01%
-3.1%
1.1M
|
Health Technology
|
-2.73%
|
O:
-0.49%
H:
2.25%
C:
-2.25%
TXMD
|
News
|
$1.88
-1.05%
-1.06%
29K
|
Health Technology
|
-0.53%
|
O:
2.63%
H:
3.59%
C:
-3.08%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
0.52%
|
O:
1.0%
H:
0.19%
C:
-0.47%
PTCT
|
News
|
$25.19
-0.4%
-0.4%
670K
|
Health Technology
|
-0.51%
|
O:
0.83%
H:
0.0%
C:
-1.33%
NKTR
|
News
|
$1.345
-9.73%
-10.78%
3.3M
|
Health Technology
|
-9.4%
|
O:
-0.67%
H:
1.35%
C:
-8.78%
MOR
|
News
|
$18.03
0.45%
0.44%
400K
|
Health Technology
|
0.5%
|
O:
0.17%
H:
0.39%
C:
0.33%
GLPG
|
News
|
$29.25
-0.81%
-0.82%
190K
|
Health Technology
|
-0.92%
|
O:
-0.14%
H:
0.17%
C:
-0.78%
AMRN
|
News
|
$0.9249
3.24%
3.14%
880K
|
Health Technology
|
3.69%
|
O:
3.69%
H:
0.0%
C:
0.0%
GOOGL
|
News
|
$155.45
0.68%
0.68%
21M
|
Technology Services
|
0.93%
|
O:
1.03%
H:
0.94%
C:
-0.1%
GOOG
|
News
S
|
$156.88
0.56%
0.56%
16M
|
Technology Services
|
0.77%
|
O:
0.97%
H:
0.95%
C:
-0.2%
OCX
|
News
J
|
$2.75
4.89%
36K
|
Health Technology
|
-5.82%
|
O:
-0.36%
H:
0.0%
C:
-5.47%
biopharma
sanofi
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
Published:
2024-04-17
(Crawled : 13:00)
- globenewswire.com
GTHX
|
News
|
$4.28
4.9%
4.67%
690K
|
Health Technology
|
4.9%
|
O:
1.72%
H:
4.82%
C:
3.13%
first
therapeutics
financial
results
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
Published:
2024-04-17
(Crawled : 13:00)
- globenewswire.com
ALLR
|
News
|
$1.505
-10.42%
-11.63%
1.1M
|
n/a
|
-9.52%
|
O:
-9.52%
H:
0.0%
C:
0.0%
nasdaq
extension
therapeutics
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
Published:
2024-04-17
(Crawled : 13:00)
- biospace.com/
STOK
|
News
|
$11.75
-5.62%
-5.96%
740K
|
Health Technology
|
-5.86%
|
O:
0.48%
H:
3.68%
C:
-6.31%
commercial
therapeutics
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
WINT
|
News
|
$0.3903
-7.4%
-7.99%
110K
|
Health Technology
|
-4.17%
|
O:
0.62%
H:
0.0%
C:
-4.76%
business
key
therapeutics
financial
results
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
CLDX
|
News
|
$39.66
2.75%
2.67%
910K
|
Health Technology
|
0.23%
|
O:
0.23%
H:
0.0%
C:
0.0%
urticaria
study
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
SAGE
|
News
|
$12.585
-19.48%
-24.2%
4.3M
|
Health Technology
|
-17.57%
|
O:
-15.02%
H:
3.55%
C:
-3.01%
sage-718
disease
treatment
topline
parkinson’s
therapeutics
results
study
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Published:
2024-04-17
(Crawled : 05:00)
- globenewswire.com
TCRX
|
News
0 d
|
$6.76
-5.19%
-5.47%
1.6M
|
Professional, Scientific, and T...
|
-9.15%
|
O:
-2.15%
H:
1.24%
C:
-7.15%
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
-0.14%
|
O:
-0.14%
H:
0.0%
C:
0.0%
million
offering
therapeutics
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published:
2024-04-17
(Crawled : 01:00)
- alteritytherapeutics.com
ATHE
|
News
|
$1.98
-3.42%
-3.54%
120K
|
Health Technology
|
-14.29%
|
O:
-14.29%
H:
0.0%
C:
0.0%
disease
neurology
system
meeting
parkinson’s
therapeutics
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
Published:
2024-04-17
(Crawled : 00:00)
- globenewswire.com
ACRV
|
News
P
|
$10.34
9.19%
8.41%
290K
|
|
10.83%
|
O:
3.32%
H:
8.82%
C:
7.26%
acr-368
acr-2316
pipeline
ongoing
preclinical
for
therapeutics
oncosignature
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Published:
2024-04-16
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
0.63%
|
O:
0.12%
H:
0.51%
C:
0.51%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
0.52%
|
O:
1.0%
H:
0.19%
C:
-0.47%
management
company
cell
nurown
trial
therapeutics
Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published:
2024-04-16
(Crawled : 22:00)
- globenewswire.com
NRIX
1 d
|
$14.1
-3.75%
-3.9%
970K
|
Health Technology
|
-3.89%
|
O:
3.07%
H:
0.79%
C:
-6.75%
offering
therapeutics
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Published:
2024-04-16
(Crawled : 20:00)
- globenewswire.com
TCRX
|
News
0 d
|
$6.76
-5.19%
-5.47%
1.6M
|
Professional, Scientific, and T...
|
-9.15%
|
O:
-2.15%
H:
1.24%
C:
-7.15%
MS
|
News
0 d
|
$90.08
1.06%
-0.28%
9.5M
|
Finance
|
-0.14%
|
O:
-0.14%
H:
0.0%
C:
0.0%
million
offering
therapeutics
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
Published:
2024-04-16
(Crawled : 20:00)
- globenewswire.com
TCRX
|
News
0 d
|
$6.76
-5.19%
-5.47%
1.6M
|
Professional, Scientific, and T...
|
-9.15%
|
O:
-2.15%
H:
1.24%
C:
-7.15%
update
pipeline
therapeutics
← Previous
1
2
3
4
5
6
7
8
9
…
14
15
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.